Copyright 2010 Medical News TodayLatest Health News and Medical News posted throughout the day, every day.http://www.medicalnewstoday.com/sections/lung_cancer/admin@medicalnewstoday.com (MNT Admin)editors@medicalnewstoday.com (MNT Editors)en-us Tue, 09 Feb 2010 07:00:00 PSThttp://mnt.to/f/3xq2http://mnt.to/f/3xq2IDBS, the leading worldwide provider of research data management and analytics solutions to R&D organizations, announced that its Biomarker Discovery and Validation Solution will be a key component in an $11 million National Heart, Lung and Blood Institute (NHLBI) award to create a molecular roadmap for chronic lung diseases...Respiratory / Asthma Sat, 06 Feb 2010 01:00:00 PSThttp://mnt.to/f/3xjYhttp://mnt.to/f/3xjYAccuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that more than 12,000 courses of lung cancer treatment have been completed with CyberKnife radiosurgery. Usage of CyberKnife radiosurgery for lung cancer continues to grow, as illustrated by a 25 percent increase year over year in calendar year 2009...Lung Cancer Fri, 05 Feb 2010 04:00:00 PSThttp://mnt.to/f/3xh6http://mnt.to/f/3xh62010: Year of the Lung is a global initiative instituted by the Forum of International Respiratory Societies (FIRS), a collaboration of the world's leading professional respiratory organizations. 2010: Year of the Lung aims to raise awareness of and advocate for lung health globally and at the country level to reduce lung disease morbidity and mortality.Learn more on The Year of the Lung website...Respiratory / Asthma Tue, 02 Feb 2010 03:00:00 PSThttp://mnt.to/f/3x6mhttp://mnt.to/f/3x6mDr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can "clean" cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer. Their work has given drug designers a new target which will allow them to develop treatments for all these cancers in which WT1 expression is elevated...Lymphoma / Leukemia / Myeloma Wed, 27 Jan 2010 02:00:00 PSThttp://mnt.to/f/3wPwhttp://mnt.to/f/3wPwYM BioSciences Inc. (NYSE YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab...Lung Cancer Tue, 26 Jan 2010 16:00:00 PSThttp://mnt.to/f/3wNrhttp://mnt.to/f/3wNrMedical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced that it has received FDA 510(k) clearance of its Therapeutic Lung Flute®...Lung Cancer Mon, 25 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wJChttp://mnt.to/f/3wJCFour scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies. The grants will fund three separate research projects at the Phoenix-based institute in the next several years. Ronald J...Smoking / Quit Smoking Mon, 25 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wJZhttp://mnt.to/f/3wJZA study published on bmj.com today reports that people diagnosed with early stage lung cancer can double their chances of survival over five years if they stop smoking compared with those who continue to smoke. This is the first evaluation of several studies that assess the effects of continued smoking after diagnosis of lung cancer...Lung Cancer Thu, 21 Jan 2010 23:00:00 PSThttp://mnt.to/f/3wDjhttp://mnt.to/f/3wDjScientists at The Methodist Hospital Research Institute in Houston received a research grant from the Cancer Prevention Research Institute of Texas (CPRIT) today to develop the first molecular image guided system to diagnose and treat small-cell peripheral lung cancer in one sitting...Lung Cancer Thu, 21 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wCchttp://mnt.to/f/3wCcAgennix AG (FRANKFURT: AGX) announced that the next stage of the FORTIS-M trial has begun, with the first patient being dosed in Europe. FORTIS-M is a Phase 3 registration trial evaluating oral talactoferrin versus placebo in advanced non-small cell lung cancer (NSCLC) in patients whose disease has progressed following two or more prior therapies...Lung Cancer Wed, 20 Jan 2010 09:00:00 PSThttp://mnt.to/f/3wykhttp://mnt.to/f/3wykLeafy green vegetables, folate, and some multivitamins could serve as protective factors against lung cancer in current and former smokers, according to a study that is a first step in understanding a complex association. The study was led by Steve Belinsky, Ph.D. and other researchers at the institute in ABQ, NM...Nutrition / Diet Wed, 20 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wy4http://mnt.to/f/3wy4ONCOLOGY: Nlp: all new tumor-forming protein Proteins that when expressed out of context cause a cell to become cancerous are known as oncogenic proteins...Cancer / Oncology Wed, 20 Jan 2010 03:00:00 PSThttp://mnt.to/f/3wxkhttp://mnt.to/f/3wxkA team of researchers, led by Yi-Ching Wang, at National Cheng Kung University, Taiwan, Republic of China, has uncovered a potential mechanism by which the tobacco-specific carcinogen NNK promotes lung tumor formation and development...Lung Cancer Wed, 20 Jan 2010 02:00:00 PSThttp://mnt.to/f/3wwMhttp://mnt.to/f/3wwMEven when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell...Lung Cancer Wed, 20 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wwKhttp://mnt.to/f/3wwKGenerally, after traditional open-chest surgery for lung cancer, patients may experience a significant amount of pain and spend up to a week in the hospital followed by months recovering...Lung Cancer Wed, 20 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wwLhttp://mnt.to/f/3wwLRepeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals...Smoking / Quit Smoking Tue, 19 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wtWhttp://mnt.to/f/3wtWAdverse events in childhood have been linked to an increase in the likelihood of developing lung cancer in later life. Researchers writing in the open access journal BMC Public Health describe how the link is partly explained by raised rates of cigarette smoking in victims of childhood trauma, but note that other factors may also be to blame...Lung Cancer Mon, 18 Jan 2010 03:00:00 PSThttp://mnt.to/f/3wsLhttp://mnt.to/f/3wsLOSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S...Lung Cancer Fri, 15 Jan 2010 01:00:00 PSThttp://mnt.to/f/3wmchttp://mnt.to/f/3wmcThe American Association for Cancer Research and the International Association for the Study of Lung Cancer (IASLC) honored Paul A. Bunn Jr., M.D., for his leadership in lung cancer research at the first Molecular Origins of Lung Cancer conference this week. The conference, held from Jan. 11-14, 2010, drew more than 300 people from around the world...Lung Cancer Thu, 14 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wk5http://mnt.to/f/3wk5Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant to first-line chemotherapy...Lung Cancer Wed, 13 Jan 2010 18:00:00 PSThttp://mnt.to/f/3wgshttp://mnt.to/f/3wgsA study recently conducted by US Oncology and Aetna (NYSE:AET) finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes...Lung Cancer Wed, 13 Jan 2010 07:00:00 PSThttp://mnt.to/f/3wfqhttp://mnt.to/f/3wfqPatients with non-small cell lung cancer in whom treatment with gefitinib is ineffective often have limited options, but results of a new study suggest that retreating patients with the same drug could have a beneficial effect. "The key may be in tumor heterogeneity," said In-Jae Oh, M.D., Ph.D., assistant professor in Chonnam National University Hwasun Hospital in the Republic of Korea...Lung Cancer Wed, 13 Jan 2010 06:00:00 PSThttp://mnt.to/f/3wfphttp://mnt.to/f/3wfp Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of their tumors had a much greater response to a new therapy - an ALK-inhibitor. Findings were presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held here from Jan...Lung Cancer Wed, 13 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wfjhttp://mnt.to/f/3wfjOf the nearly 150,000 abnormal chest X-rays performed each year in the United States, 25 percent of patients will display only benign lung pathologies on further surgical examination. This false-positive rate has important clinical implications in cost and side effects...Lung Cancer Wed, 13 Jan 2010 04:00:00 PSThttp://mnt.to/f/3wfkhttp://mnt.to/f/3wfkAt least three tumor microRNAs appear to predict when first-line chemotherapy will prove ineffective in some patients with small cell lung cancer, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held Jan. 11-14, 2010. "For patients with small cell lung cancer, there are really only about two chemotherapy options...Lung Cancer